Addus HomeCare (ADUS) Scheduled to Post Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is scheduled to be announcing its earnings results after the market closes on Monday, November 4th. Analysts expect the company to announce earnings of $1.14 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.14. The company had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.94 EPS. On average, analysts expect Addus HomeCare to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $126.27 on Friday. Addus HomeCare has a fifty-two week low of $80.68 and a fifty-two week high of $136.12. The company has a market cap of $2.29 billion, a PE ratio of 29.92, a P/E/G ratio of 2.28 and a beta of 1.04. The business has a 50-day simple moving average of $130.16 and a two-hundred day simple moving average of $119.90.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at $429,165. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts have weighed in on ADUS shares. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 target price on shares of Addus HomeCare in a research report on Tuesday, September 3rd. KeyCorp assumed coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Macquarie restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Friday, October 11th. TD Cowen boosted their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Finally, Stephens restated an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $131.38.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.